Long Covid: could chronic fatigue syndrome be taken seriously at last?
‘Long Covid’ has become shorthand for a wide range of post-viral symptoms experienced by some patients following a Covid-19 infection.…
ByFocus box
Q&A: staving off AMR disaster with Ineos and the University of Oxford
The University of Oxford has teamed up with manufacturing company Ineos to open up a £100m institute focused on AMR…
By
EU countries suspend use of Covid-19 vaccine AstraZeneca
Several countries in Europe have suspended the University of Oxford / AstraZeneca (AZ) Covid-19 vaccine completely or partially after several…
Medical cannabis: regulating a new export market on the Isle of Man
As the Isle of Man prepares to accept applications for medical cannabis cultivation licences after introducing new regulations, what are…
By
Q&A with N-SIDE’s Sébastien Coppe: how digitisation overcomes clinical bottlenecks
The Covid-19 pandemic has transformed clinical development. Rather than taking ten years to bring a drug to market, vaccine manufacturers…
By
Veteran investor Dr Robert Glassman talks life sciences, immunotherapy and Umoja
Immunotherapy-focused Umoja has appointed veteran investor Dr Robert Glassman to its board. Glassman discusses his extensive experience at Merrill Lynch,…
By
Breast cancer research: addressing the premenopausal problem
Premenopausal women have been largely absent from hormonal breast cancer drug trials resulting in treatment delays for this patient population.…
By
Head-to-head: competition heats up as new HIV prevention drug shows promise
Trials into ViiV Healthcare’s cabotegravir have suggested it could be even more effective than the standard of care (Truvada) in…
By